IJTLD OPEN (ISSN: 3005-7590) is open access and fully compliant with Plan S.
Articles submitted to IJTLD OPEN are evaluated solely on scientific merit. IJTLD OPEN has the same values as the IJTLD, with an identical Editorial Board, peer review process and acceptance criteria.
We publish high impact research for the continuing education of academics, clinicians and other health personnel working on respiratory diseases and lung health. Our scope includes translational, clinical, epidemiological and programmatic research to find health solutions for these conditions, including the development of vaccines, diagnostics and medicines for the prevention, management and control of TB and other areas of lung health such as asthma, bronchiectasis, COVID-19, COPD and the hazards of tobacco and air pollution.
IJTLD OPEN is open access and free to read. Also, authors retain copyright and can freely distribute the PDF or upload it to any website. As a consequence, open access articles are highly downloaded and more highly cited.
Click the links below to read our content on PubMed Central, Ingenta.com or see the Table of Contents for each issue.
We invite authors with OA funding to submit their papers (including Editorials, Original Articles, Letters and Case Series) to IJTLD OPEN.
We welcome submissions on the development of vaccines, diagnostics and medicines for the prevention, management and control of TB and all other respiratory diseases.
This includes basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for these conditions.
For all queries please e-mail the Editorial Office
Sponsorship
Supplements and article series are a highly-effective way of highlighting a specific topic to researchers, clinicians and decision makers in respiratory health.
Being an Open Access journal, IJTLD OPEN has no barriers to access and can reach readers in health centres, medical, university and pharmaceutical institutes, along with civil society, patients and carers.
All content will be freely available on Ingenta.com and we will have regular mailings to highlight the latest sponsored content.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD, IJTLD OPEN and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
How TB and COVID-19 compare: an opportunity to integrate both control programmes
Letter to the editors which highlights similarities and differences between TB and COVID-19 – and proposes that control programmes unite to address both conditions.
COVID-19: ensuring continuity of TB services in the private sector
Pakistan has the fifth largest global burden of TB, and in response to COVID-19 a lockdown was imposed on 26 February. TB services were severely disrupted. This threatened to undermine recent gains in private-sector engagement and TB elimination efforts.
Responding to COVID-19: adjusting TB services in a low-burden setting
A letter to the editors in which the Victorian Tuberculosis Program describes how the social and programmatic changes to TB services brought on by COVID-19 have been experienced in practice.
COVID-19 in Africa: community and digital technologies for tuberculosis management
This letter explores the concerns about the negative impact that COVID-19 will have on the fight against tuberculosis in Africa
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic
This letter looks at the implications and potential consequences of delayed or missed diagnoses for TB, which may increase TB-related hospitalisations and death.
COVID-19 and tuberculosis—threats and opportunities
In an editorial to the IJTLD, the authors state how we must overcome the challenges that COVID-19 presents and use the opportunities it affords us to achieve a paradigm shift in TB treatment and care